Skip to main content

Tessari Eben's Form 4 filing

Kiniksa Pharmaceuticals International, plc (KNSA) · filed Aug 7, 2025

Accession no.
0001415889-25-021271
Filed
Aug 7, 2025
Trade date
Jul 15-Aug 5, 2025
Filing delay
23 daysLate
Rule 10b5-1 plan
Checked

This filing lists 8 non-derivative transactions and 5 derivative transactions. Open-market sales total $4.60M. It was filed 23 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Tessari EbenCIK 0001867899Officer (CHIEF OPERATING OFFICER)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 15, 2025Class A Ordinary ShareAGrant or awardAcquired+752$15.63+$11,753.7649,915Direct
Aug 5, 2025Class A Ordinary ShareMOption exerciseAcquired+38,928$10.36+$403,294.0888,843Direct
Aug 5, 2025Class A Ordinary ShareMOption exerciseAcquired+30,444$12.97+$394,858.68119,287Direct
Aug 5, 2025Class A Ordinary ShareMOption exerciseAcquired+32,710$11.10+$363,081151,997Direct
Aug 5, 2025Class A Ordinary ShareMOption exerciseAcquired+25,896$11.97+$309,975.12177,893Direct
Aug 5, 2025Class A Ordinary ShareMOption exerciseAcquired+10,636$10.76+$114,443.36188,529Direct
Aug 5, 2025Class A Ordinary ShareSSaleDisposed−138,064$33.20−$4,583,724.850,465Direct
Aug 5, 2025Class A Ordinary ShareSSaleDisposed−550$33.90−$18,64549,915Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 5, 2025Class A Ordinary ShareMOption exerciseDisposed−38,928$0.00$00Direct
Aug 5, 2025Class A Ordinary ShareMOption exerciseDisposed−30,444$0.00$016,694Direct
Aug 5, 2025Class A Ordinary ShareMOption exerciseDisposed−32,710$0.00$032,710Direct
Aug 5, 2025Class A Ordinary ShareMOption exerciseDisposed−25,896$0.00$039,524Direct
Aug 5, 2025Class A Ordinary ShareMOption exerciseDisposed−10,636$0.00$031,908Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)